Beijing Tongrentang: Market Snapshot, IPO Pause, and Strategic Outlook in 2026
Beijing Tongrentang’s latest market snapshot reveals flat trading, a 5% rise versus month‑end, and a strategic pause amid stricter IPO scrutiny for Chinese pharma.
3 minutes to read